Biochemistry & Physiology: Open Access
Open Access

In recent years, the rapid detection of pathogens has become a cornerstone of modern healthcare, food safety, and environmental monitoring. The rise of infectious diseases, coupled with the increasing threat of antimicrobial resistance, has underscored the need for fast, sensitive, and cost-effective diagnostic tools. Traditional methods, such as culture-based techniques and polymerase chain reaction (PCR), while reliable, often require specialized equipment, trained personnel, and significant time to yield results. These limitations have driven the development of innovative technologies, among which optical biosensors have emerged as a promising solution [1].

Optical biosensors leverage the interaction of light with biological elements to detect pathogens with high specificity and sensitivity. These devices translate biomolecular interactions into measurable optical signals, such as changes in absorbance, fluorescence, or refractive index. Their appeal lies in their versatility, portability, and potential for real-time monitoring, making them suitable for point-of-care (POC) applications and resource-limited settings. As of March 28, 2025, advancements in nanotechnology, materials science, and data analytics have propelled optical biosensors to the forefront of pathogen detection, with emerging trends reshaping their design and functionality. This article explores these trends, delving into their mechanisms, applications, and future potential [2].

Description

Integration of nanomaterials

One of the most transformative trends in optical biosensors is the integration of nanomaterials, such as gold nanoparticles (AuNPs), quantum dots (QDs), and graphene derivatives. These materials enhance the sensitivity and signal amplification of optical detection systems. For instance, AuNPs exhibit localized surface plasmon resonance (LSPR), a phenomenon where light interacts with electrons on the nanoparticle surface, producing sharp optical signals. This property has been harnessed to detect pathogens like Escherichia coli and Salmonella at ultralow concentrations. Recent studies have shown that functionalizing AuNPs with pathogen-specific antibodies or aptamers can improve detection limits to the single-cell level [3].

Quantum dots, semiconductor nanocrystals with size-tunable fluorescence, offer another leap forward. Their bright, stable emission enables multiplexed detection simultaneously identifying multiple pathogens in a single sample. In 2024, researchers developed a QD-based biosensor capable of distinguishing between Staphylococcus aureus and Pseudomonas aeruginosa in wound infections, reducing diagnostic time from hours to minutes. Similarly, graphene-based materials, with their large surface area and excellent optical properties, have been incorporated into surface-enhanced Raman scattering (SERS) platforms, boosting signal intensity for detecting viral pathogens like SARS-CoV-2.

Smartphone-based optical sensing

The ubiquity of smartphones has spurred a trend toward integrating optical biosensors with mobile devices, democratizing pathogen detection. Smartphone cameras, equipped with high-resolution sensors, can capture optical signals from biosensors, while onboard processing power analyzes the data. This trend aligns with the growing demand for POC diagnostics, particularly in low-resource regions where laboratory infrastructure is scarce [4].

A notable example is the development of paper-based optical biosensors paired with smartphone readers. These devices use colorimetric or fluorescent assays, where a pathogen’s presence triggers a visible color change or light emission detectable by the smartphone camera. In 2023, a team engineered a smartphone-compatible biosensor for detecting Listeria monocytogenes in food samples, achieving results comparable to lab-based methods within 30 minutes. Advances in 3D-printed optical attachments and machine learning algorithms have further refined these systems, enabling quantitative analysis and cloud-based data sharing for epidemiological tracking [5].

Label-free detection techniques

Label-free optical biosensors, which eliminate the need for fluorescent tags or secondary reporters, are gaining traction due to their simplicity and cost-effectiveness. Techniques like surface plasmon resonance (SPR) and interferometry dominate this category. SPR biosensors detect changes in the refractive index near a sensor surface caused by pathogen binding, offering real-time, label-free monitoring. Recent innovations have miniaturized SPR platforms, making them portable and suitable for field use. For example, a handheld SPR device developed in 2024 successfully identified Mycobacterium tuberculosis in sputum samples with a sensitivity rivaling PCR [6].

Interferometric biosensors, such as those based on Mach-Zehnder or Fabry-Perot configurations, measure phase shifts in light waves induced by biomolecular interactions. These systems have shown promise in detecting viral antigens, including influenza and dengue, with minimal sample preparation. The shift toward label-free methods reduces assay complexity and cost, paving the way for scalable production and widespread adoption.

Wearable and In Situ optical biosensors

The rise of wearable technology has extended to optical biosensors, enabling continuous pathogen monitoring in real-world settings. These devices, often embedded in fabrics or skin-adherent patches, use optical fibers or miniaturized photonic components to detect pathogens in sweat, saliva, or exhaled breath. A breakthrough in 2025 involved a wearable fiber-optic sensor that monitors Streptococcus pneumoniae levels in respiratory secretions, alerting users to early signs of pneumonia. Such systems integrate with wireless networks, providing healthcare providers with real-time data for timely intervention [7].

In situ biosensors, designed for environmental and food safety applications, represent another frontier. Optical sensors embedded in water filtration systems or food packaging can detect pathogens like Vibrio cholerae or Campylobacter on-site, reducing reliance on centralized testing. These devices often employ waveguide-based optics or photonic crystals, which offer high sensitivity and durability in harsh conditions.

Artificial intelligence and Data integration

The convergence of optical biosensors with artificial intelligence (AI) is revolutionizing pathogen detection by enhancing data interpretation and diagnostic accuracy. AI algorithms, trained on vast datasets of optical signals, can identify subtle patterns indicative of specific pathogens, even in complex samples. For instance, a 2024 study demonstrated an AI-powered SERS biosensor that differentiated between closely related bacterial strains with 98% accuracy, surpassing human analysis [8].

Moreover, AI facilitates multiplexing and predictive modeling, allowing biosensors to not only detect pathogens but also predict outbreak risks based on environmental or clinical trends. Cloud-based platforms integrate biosensor data with global health databases, enabling rapid responses to emerging threats. This synergy of AI and optical sensing is particularly impactful in combating pandemics, where speed and precision are paramount.

Advances in biorecognition elements

The specificity of optical biosensors hinges on biorecognition elements molecules like antibodies, aptamers, or peptides that bind to pathogens. Recent trends favor synthetic alternatives to traditional antibodies, such as aptamers and molecularly imprinted polymers (MIPs). Aptamers, short DNA or RNA sequences, offer high stability and ease of modification, making them ideal for detecting pathogens in diverse matrices. A 2025 innovation involved an aptamer-based SPR sensor for Clostridium difficile, achieving detection in under 15 minutes [9].

MIPs, synthetic polymers with pathogen-specific cavities, mimic natural receptors while withstanding extreme conditions. Their integration into optical biosensors has improved robustness, particularly for environmental monitoring. These advances ensure that optical biosensors remain effective across varied applications, from clinical diagnostics to industrial safety [10].

Conclusion

The evolution of optical biosensors for pathogen detection reflects a dynamic interplay of science, engineering, and societal needs. As of March 28, 2025, emerging trends—nanomaterial integration, smartphone compatibility, label-free techniques, wearable designs, AI enhancement, and novel biorecognition element shave elevated these devices beyond traditional diagnostics. They offer unparalleled sensitivity, speed, and accessibility, addressing challenges in healthcare, food security, and environmental protection. Looking ahead, the future of optical biosensors lies in their scalability and adaptability. Continued investment in interdisciplinary research will refine their performance, while regulatory frameworks will ensure their safe deployment. As global threats like pandemics and antibiotic resistance persist, optical biosensors stand poised to transform pathogen detection, delivering solutions that are not only technologically advanced but also equitable and impactful. This convergence of innovation and necessity heralds a new era in biosensing, where light illuminates the path to a healthier, safer world.

Acknowledgement

None

Conflict of Interest

None

References

1. Alloui MN, Szczurek W, Swiątkiewicz S (2013) The usefulness of prebiotics and probiotics in modern poultry nutrition: a review. Ann Anim Sci 13: 17–32.

   Indexed at, Google Scholar, Crossref

2. Aluwong T, Kawu M, Raji M, Dzenda T, Govwang F, et al. (2013) Effect of yeast probiotic on growth, antioxidant enzyme activities and malondialdehyde concentration of broiler chickens. Antioxidants 2: 326–339.

   Indexed at, Google Scholar, Crossref

3. Awad WA, Ghareeb K, Raheem AS, Böhm J (2009) Effects of dietary inclusion of probiotic and synbiotic on growth performance, organ weights, and intestinal histomorphology of broiler chickens. Poultry Sci 88: 49–56.

   Indexed at, Google Scholar, Crossref

4. Barham D, Trinder P (1972) An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97: 142–145.

   Indexed at, Google Scholar, Crossref

5. Begley M, Hill C, Gahan CG (2006) Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72: 1729–1738.

   Indexed at, Google Scholar, Crossref

6. Begum J, Mir NA, Dev K, Khan IA (2018) Dynamics of antibiotic resistance with special reference to Shiga toxin-producing Escherichia coli infections. J Appl Microbiol 125: 1228–1237.

   Indexed at, Google Scholar, Crossref

7. Cetin N, Guclu BK, Cetin E (2005) The effects of probiotic and mannanoligosaccharide on some haematological and immunological parameters in turkeys. J Vet Med 52: 263–267.

   Indexed at, Google Scholar, Crossref

8. Chiang YR, Ismail W, Heintz D, Schaeffer C, Dorsselaer A, et al. (2008) Study of anoxic and oxic cholesterol metabolism by sterolibacterium denitrificans. J Bacteriol 190: 905–914.

   Indexed at, Google Scholar, Crossref

9. Dikeman CL, Murphy MR, Fahey GC (2006) Dietary fibers affect viscosity of solutions and simulated human gastric and small intestinal digesta. J Nutr 136: 913–919.

   Indexed at, Google Scholar, Crossref

10. Mikelsaar M, Zilmer M (2009) Lactobacillus fermentum ME-3–an antimicrobial and antioxidative probiotic. Microb Ecol Health Dis 21: 1–27.

    Indexed at, Google Scholar, Crossref